(VIANEWS) – The NASDAQ opens in less than two hours and Illumina‘s pre-market value is already 5.49% down.
Illumina’s last close was $138.04, 42.13% under its 52-week high of $238.55.
The last session, NASDAQ ended with Illumina (ILMN) sliding 2.11% to $138.04. NASDAQ jumped 0.02% to $14,972.76, following the last session’s upward trend on what was a somewhat positive trend exchanging session.
About Illumina
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, Illumina has a trailing twelve months EPS of $-7.1.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.82%.
Sales Growth
Illumina’s sales growth is negative 1% for the current quarter and negative 3.4% for the next.
Yearly Top and Bottom Value
Illumina’s stock is valued at $138.04 at 08:24 EST, way below its 52-week high of $238.55 and way higher than its 52-week low of $89.00.
Revenue Growth
Year-on-year quarterly revenue growth grew by 0.4%, now sitting on 4.46B for the twelve trailing months.
Volume
Today’s last reported volume for Illumina is 1564798 which is 42.29% below its average volume of 2711710.
More news about Illumina (ILMN).
